Open
SectorHealthcare
134.06 -8.59
24h
Min
132.91
Max
149.75
Income | 100M 108M |
|---|---|
Sales | 115M 688M |
P/E Sector Avg | 41.446 37.461 |
Profit margin | 15.636 |
Employees | 1,800 |
EBITDA | 129M 153M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +13.65% upside |
Market Cap | 785M 14B |
|---|---|
Previous open | 142.65 |
Previous close | 134.06 |
By Acuity
50%
50%
154 / 373 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 169.27 USD 13.65%
High 200 USD
Low 124 USD
Based on 25 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$